Combining COPD with Clinical, Pathological and Demographic Information Refines Prognosis and Treatment Response Prediction of Non-Small Cell Lung Cancer
Figure 2
Comprehensive prognostic model for lung adenocarcinoma.
Patient survival at 60 months for the total population sample is shown for the range of Hazard Scores (left), with the risk-groups delimited by vertical bars. Model coefficients used to determine the Hazard Score for each patient are shown on the forest plot (right). A: AJCC 3rd Staging Edition; B: AJCC 6th Staging Edition; C: AJCC 7th Staging Edition.